Media Invitation: 2nd ESMO Scientific & Educational Conference (ESEC), 2-5 June 2005, Budapest, HungaryMarch 14, 2005ESEC 2005 Highlights * The future in genomics and proteomics * Assessing risk in cancer patients * Avoiding side-effects of cancer therapy * Immunotherapies * Development of cancer-killing viruses * How communities can fight tobacco addiction * State-of-the-art oncology for various tumor types Some other special features * New and updated ESMO Minimum Clinical Recommendations will present a global overview on current ESMO clinical guidelines used in everyday practice. * An ESMO Handbook on Oncological Emergencies (the first in a series) will launch and be distributed to all oncologists attending the conference. * A keynote lecture on the status of oncology in Central and Eastern European Countries will address differences in cancer epidemiology. * A fourth ESMO Patient Seminar on cancer in Eastern Europe will be organized for local patients to meet international oncologists, as well as share and discuss experiences on available cancer treatments. * The second Young Medical Oncologists Masterclass will provide young doctors with an expert insight and valuable suggestions on scientific publications and research. * Oncology Highlights of the most important advances in cancer treatment presented at other cancer conferences. Scheduled Press Conference Friday, 3 June 2005, 13:00-14:00 Topics to be confirmed. European Society for Medical Oncology (ESMO) |
|||||||||||||||||||||
| Related Cancer Current Events and Cancer News Articles Menopause-cardiology consensus statement on cardiovascular disease and on HRT A menopause-cardiology consensus statement has called for direct action to prevent cardiovascular disease (CVD) in menopausal women. The statement also concludes that there is little evidence of increased CVD risk in taking HRT. Other Illnesses, Body Weight Do Not Explain Racial Disparities in Colon Cancer Survival, UAB Researchers Say A new study by University of Alabama at Birmingham (UAB) researchers shows that body-mass index (BMI) and co-existing medical conditions (co-morbidity) do not explain the decreased survival observed among African-Americans compared to Caucasians who also have colon cancer. Multiple health concerns surface as winter, vitamin D deficiences arrive A string of recent discoveries about the multiple health benefits of vitamin D has renewed interest in this multi-purpose nutrient, increased awareness of the huge numbers of people who are deficient in it, spurred research and even led to an appreciation of it as "nature's antibiotic." AIDS research reveals a lack of family-planning programs in Uganda University of Alberta graduate student Jennifer Heys wants to make her message clear: there needs to be more education in Ugandan communities about contraception. Possible Link Studied Between Childhood Abuse and Early Cellular Aging Children who suffer physical or emotional abuse may be faced with accelerated cellular aging as adults, according to new research from Butler Hospital and Brown University. Rare pancreatic cancer patients may live longer when treated with radiation therapy Radiation therapy is effective in achieving local control and palliation in patients with pancreatic neuroendocrine tumors (PNTs), despite such tumors being commonly considered resistant to radiation therapy. Researchers Identify Role of Gene in Tumor Development, Growth and Progression Virginia Commonwealth University Massey Cancer Center and VCU Institute of Molecular Medicine researchers have identified a gene that may play a pivotal role in two processes that are essential for tumor development, growth and progression to metastasis. Saving the single cysteine: new antioxidant system found We've all read studies about the health benefits of having a life partner. The same thing is true at the molecular level, where amino acids known as cysteines are much more vulnerable to damage when single than when paired up with other cysteines. Gene mismatch influences success of bone marrow transplants A commonly inherited gene deletion can increase the likelihood of immune complications following bone marrow transplantation, an international team of researchers reports in the November 22 advance online issue of Nature Genetics. Cancer metabolism discovery uncovers new role of IDH1 gene mutation in brain cancer Agios Pharmaceuticals today announced that its scientists have established, for the first time, that the mutated IDH1 gene has a novel enzyme activity consistent with a cancer-causing gene, or oncogene. More Cancer Current Events and Cancer News Articles |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||